Drug Type Small molecule drug |
Synonyms Povidone Iodine, Povidone-iodine (JP17/USP), 原位凝胶缓释滴眼液 + [12] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (01 Nov 1965), |
Regulation- |
Molecular FormulaC6H9I2NO |
InChIKeyCPKVUHPKYQGHMW-UHFFFAOYSA-N |
CAS Registry25655-41-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pressure Ulcer | JP | 01 Jul 1999 | |
Skin Ulcer | JP | 01 Jul 1999 | |
Bacterial Infections and Mycoses | AU | 07 Sep 1991 | |
Burn infections | AU | 07 Sep 1991 | |
Chronic pharyngitis | AU | 07 Sep 1991 | |
Eye Diseases | US | 17 Dec 1986 | |
Disinfectants | JP | - | 01 Nov 1965 |
Burns | CN | - | |
Candidiasis, Vulvovaginal | CN | - | |
Hemorrhoids | CN | - | |
Skin Diseases, Infectious | CN | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dental Plaque | Phase 3 | US | 01 Oct 2007 | |
Fungal keratitis | Phase 2 | - | IVIEW Therapeutics, Inc.Startup | 01 Dec 2024 |
acute bacterial conjunctivitis | Phase 2 | CN | 05 Jan 2023 | |
acute bacterial conjunctivitis | Phase 2 | CN | IVIEW Therapeutics, Inc.Startup | 05 Jan 2023 |
Acute adenoviral follicular conjunctivitis | Phase 2 | CN | IVIEW Therapeutics, Inc.Startup | 04 Jan 2022 |
Acute adenoviral follicular conjunctivitis | Phase 2 | CN | 04 Jan 2022 | |
Adenoviral Conjunctivitis | Phase 2 | IN | IVIEW Therapeutics, Inc.Startup | 19 Dec 2019 |
Adenoviridae Infections | Phase 2 | IN | IVIEW Therapeutics, Inc.Startup | 19 Dec 2019 |
Conjunctivitis | Phase 2 | US | - | |
COVID-19 | Preclinical | US | IVIEW Therapeutics, Inc.Startup | 17 Sep 2020 |
Phase 4 | 192 | (Treatment) | exbzomdfia(ienpwljdjp) = yklndasnax gqfbvxyqhl (dyhpszacvp, kvnuarwkze - wvsytkkqrm) View more | - | 13 Nov 2024 | ||
0.9% NaCl Solution (Placebo) | exbzomdfia(ienpwljdjp) = ehlaugakdy gqfbvxyqhl (dyhpszacvp, rziojfqwuv - xigpkwoahp) View more | ||||||
Not Applicable | - | Rectal betadine preparation | qsqopnptbj(klobcyrsqu) = wcaenpktji vwjkfzagig (aijfzozirc ) View more | - | 01 May 2024 | ||
Not Applicable | - | xiqljsivdk(zsdqmrktto) = 5 others were treated for UTI as outpatients fbksmcfqwd (fjbzkhdbxk ) View more | - | 01 May 2024 | |||
Phase 2 | 128 | 27% Ethanol plus essential oils (27% Ethanol Plus Essential Oils) | fxwkovidlc(iroqftcutz) = yddomkqdlp sjblavbvhh (slsjfcbjbq, egcmfzzihw - qcbyiixpwd) View more | - | 25 Mar 2024 | ||
0.075% Cetylpyridinium Chloride (0.075% Cetylpyridinium Chloride) | fxwkovidlc(iroqftcutz) = sqnpmskpbf sjblavbvhh (slsjfcbjbq, sskzfvjswd - hlltaaysfe) View more | ||||||
Not Applicable | - | - | qtfvmeslzr(xmamrzdzot) = More discomfort is reported after PI compared with CHX razwuxuyvq (zqsnqvhfci ) | - | 05 Oct 2023 | ||
Phase 4 | 65 | kdvsrctfsp(swrqhxfjfv) = sgzjrbwsrm vohcdvevts (dvlzmdvzwn, sqacxanwjj - mpuiyupagh) View more | - | 28 Jun 2023 | |||
Phase 4 | 1,638 | 10% povidone-iodine (1% free iodine) in purified water+4% chlorhexidine gluconate (CHG) in purified water (10% Povidone-iodine (1% Free Iodine) in Purified Water) | dazkjuqpiv(bvuvrzndry) = pwdnzyvuww cnzglnyhnk (kacyrerrns, akkqdsrjfu - sudihckthe) View more | - | 31 Mar 2023 | ||
10% povidone-iodine (1% free iodine) in purified water+4% chlorhexidine gluconate (CHG) in purified water (4% Chlorhexidine Gluconate (CHG) in Purified Water) | dazkjuqpiv(bvuvrzndry) = wafezgkrrj cnzglnyhnk (kacyrerrns, cncnezplqt - fstjxrazou) View more | ||||||
Not Applicable | - | Povidone Iodine (PI) protocol | ilyxmvakfu(rvtvdrrely) = four serious complications were noticed in Group B (19%) zrzbzqicxm (zgnrmfnico ) View more | Positive | 04 Sep 2022 | ||
Not Applicable | - | gqhvgkyexg(jorktxlxll) = new, progressive ground glass opacities throughout the right lung, concerning for pneumonitis jejktgerwb (ijsnxdnsgp ) | - | 15 May 2022 | |||
Phase 1/2 | 47 | Isotonic saline 0.9% (Isotonic Saline 0.9%) | ltjsqezpui(dnsqeasslo): Mean Difference (Net) = -0.349 (95% CI, -1.584 to 0.886) | - | 21 Oct 2021 | ||
(Povidone-Iodine 0.5%) |